Insider: Venker Eric President & Immunovant CEO - Roivant Sciences Ltd.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,504,959 | 0 | 1,504,959 |
| Value | $22,830,228.03 | $0.00 | $22,830,228.03 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/23/2025 | DDS | 611,000 | Direct | COM | $14.83 | $9,061,130.00 | 1,504,959 |
| 09/22/2025 | DDS | 316,182 | Direct | COM | $14.99 | $4,739,568.18 | 2,215,959 |
| 09/22/2025 | DDS | 100,000 | Direct | COM | $15.01 | $1,501,000.00 | 2,115,959 |
| 09/19/2025 | DDS | 683,818 | Direct | COM | $14.95 | $10,223,079.10 | 1,969,767 |
| 08/20/2025 | DDS | 100,000 | Direct | COM | $11.72 | $1,172,000.00 | 1,653,585 |
| 07/21/2025 | DDS | 100,000 | Direct | COM | $11.52 | $1,152,000.00 | 1,462,223 |
| 06/20/2025 | DDS | 100,000 | Direct | COM | $11.45 | $1,145,000.00 | 1,462,223 |
| 06/03/2025 | DDS | 566,278 | Direct | COM | $11.22 | $6,353,639.16 | 1,462,223 |
| 06/02/2025 | DDS | 433,722 | Direct | COM | $11.07 | $4,801,302.54 | 1,243,475 |
| 05/20/2025 | DDS | 100,000 | Direct | COM | $10.95 | $1,095,000.00 | 1,077,197 |
| 04/21/2025 | DDS | 100,000 | Direct | COM | $10.22 | $1,022,000.00 | 1,116,345 |
| 03/24/2025 | DDS | 434,478 | Direct | COM | $10.82 | $4,701,051.96 | 1,127,290 |
| 03/20/2025 | DDS | 315,522 | Direct | COM | $11.06 | $3,489,673.32 | 959,457 |
| 02/20/2025 | DDS | 100,000 | Direct | COM | $10.65 | $1,065,000.00 | 896,869 |
| 02/13/2025 | DDS | 218,041 | Direct | COM | $10.42 | $2,271,987.22 | 896,869 |
| 02/12/2025 | DDS | 217,384 | Direct | COM | $10.53 | $2,289,053.52 | 732,294 |
| 01/21/2025 | DDS | 100,000 | Direct | COM | $11.28 | $1,128,000.00 | 732,294 |
| 12/30/2024 | DDS | 177,704 | Direct | COM | $11.54 | $2,050,704.16 | 740,976 |
| 12/27/2024 | DDS | 176,900 | Direct | COM | $11.82 | $2,090,958.00 | 668,680 |
| 12/20/2024 | DDS | 100,000 | Direct | COM | $11.49 | $1,149,000.00 | 595,580 |
| 11/20/2024 | DDS | 100,000 | Direct | COM | $11.32 | $1,132,000.00 | 606,525 |
| 10/21/2024 | DDS | 100,000 | Direct | COM | $11.65 | $1,165,000.00 | 617,470 |
| 02/09/2024 | DDS | 96,950 | Direct | COM | $10.92 | $1,058,694.00 | 532,207 |
| 10/05/2023 | DDS | 153,027 | Direct | COM | $10.11 | $1,547,102.97 | 595,397 |
| 10/03/2023 | DDS | 606,221 | Direct | COM | $10.25 | $6,213,765.25 | 595,397 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research